ティブソボの世界市場レポート2025年

ティブソボの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.4％で15億5,000万米ドルに成長します。このような市場拡大が予想される背景には、標的がん治療薬への嗜好の高まり、IDH1阻害剤の広範な使用、バイオ医薬品研究開発への投資の増加、有利な規制経路などがあります。予測期間中に予想される主な動向には、精密腫瘍学の革新、戦略的提携やパートナーシップの拡大、低分子医薬品の革新の進展、規制当局の許可、治療プロトコルの進化などがあります。

急性骨髄性白血病の有病率の増加は、今後ティブソボ市場の成長を促進すると予想されます。急性骨髄性白血病（AML）は、血液や骨髄のがんであり、血液細胞の産生、免疫機能、身体全体の健康に直接影響を与える進行性のがんです。急性骨髄性白血病は主に高齢者に罹患するため、この有病率の上昇は世界の高齢化人口の増加に大きく起因しています。平均寿命の延長に伴い、このタイプの白血病を発症しやすい年齢層に達する人が増えています。ティブソボは、IDH1変異がん細胞を標的とし、正常な血球産生を回復させることにより、異常な細胞増殖を抑制し、病気の進行を抑え、治療反応を改善し、生存成績を向上させることにより、AMLに対処します。例えば、2023年2月、オーストラリアを拠点とする非営利団体Leukemia Foundationは、2022年から2035年の間に、7,000人以上の小児、6,000人以上の若年成人、10万8,000人以上の成人（25歳から65歳）が、主にALL、AML、非ホジキンリンパ腫を含む血液がんと診断されると報告しました。その結果、急性骨髄性白血病の有病率の上昇がティブソボ市場の成長を促進しています。

ティブソボ市場で事業を展開する主要企業は、薬剤のリーチを広げ、IDH1変異がんにおけるリーダーシップを維持するため、規制当局の承認取得に注力しています。薬事承認とは、医薬品の安全性と有効性が確認された後、指定された病状に対して医薬品の合法的な販売と使用を可能にする、保健当局による正式な許可のことです。例えば、2023年10月、フランスの製薬会社セルヴィエ・ラボラトワールは、欧州委員会からティブソボ（イボシデニブ錠）の承認を取得し、治療が困難な2つのがん種に対する欧州初で唯一のIDH1標的治療薬として認可されました。本薬は、標準的な導入化学療法が不適格なIDH1 R132変異を有する新規診断のAML患者に対するアザシチジンとの併用療法、および少なくとも1回の全身療法歴のある同変異を有する局所進行性または転移性胆管がんの成人患者に対する単剤療法として承認されています。希少疾病用医薬品の指定を受けた今回の承認は、重要なアンメット・メディカル・ニーズを満たすものであり、これらの患者の転帰とQOLの改善に新たな希望をもたらすものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のティブソボ：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のティブソボ市場：成長率分析
• 世界のティブソボ市場の実績：規模と成長, 2019-2024
• 世界のティブソボ市場の予測：規模と成長, 2024-2029, 2034F
• 世界のティブソボ：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のティブソボ市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 錠剤
• カプセル
• 併用療法
• 注射剤
• 世界のティブソボ市場：投与方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口投与
• 静脈内投与
• 世界のティブソボ市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のティブソボ市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がん治療
• 急性骨髄性白血病
• 化学療法
• 標的療法
• 世界のティブソボ市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 調査機関
• 在宅ケア設定
• 世界のティブソボ市場、錠剤、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口錠
• 徐放錠
• 世界のティブソボ市場、カプセル、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ソフトジェルカプセル
• ハードジェルカプセル
• 世界のティブソボ市場、併用療法、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ティブソボ+化学療法剤
• ティブソボ+標的治療薬
• 世界のティブソボ市場、注射剤、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 静脈注射
• 皮下注射

第7章 地域別・国別分析

• 世界のティブソボ市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のティブソボ市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ティブソボ市場：競合情勢
• ティブソボ市場：企業プロファイル
  • Servier Laboratoires Overview, Products and Services, Strategy and Financial Analysis
  • Agios Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

第31章 世界の市場競合ベンチマーキングとダッシュボード

第32章 主要な合併と買収

第33章 最近の市場動向

第34章 市場の潜在力が高い国、セグメント、戦略

• ティブソボ市場2029：新たな機会を提供する国
• ティブソボ市場2029：新たな機会を提供するセグメント
• ティブソボ市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第35章 付録

Tibsovo is an oral targeted therapy mainly prescribed for adults diagnosed with acute myeloid leukemia (AML) or cholangiocarcinoma that exhibit a specific mutation in the IDH1 gene. By targeting and inhibiting the mutated IDH1 enzyme, Tibsovo lowers the production of an abnormal metabolite that facilitates cancer cell proliferation, thereby aiding in the restoration of normal cell differentiation and decelerating disease advancement.

Tibsovo is available in various forms including tablets, capsules, combination therapies, and injectable options. The tablet form, which contains ivosidenib, is a convenient oral solid dosage designed for once-daily use. The drug can be administered both orally and intravenously and is distributed through hospital pharmacies, retail outlets, and online platforms. It serves several applications such as cancer therapy, AML treatment, chemotherapy, and precision-targeted therapies. These products are utilized by a range of end users including hospitals, specialized clinics, research centers, and homecare environments.

The tibsovo market research report is one of a series of new reports from The Business Research Company that provides tibsovo market statistics, including tibsovo industry global market size, regional shares, competitors with a tibsovo market share, detailed tibsovo market segments, market trends and opportunities, and any further data you may need to thrive in the tibsovo industry. This tibsovo market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tibsovo market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.08 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. Growth in the historical period has been driven by the rising incidence of AML, increased identification of IDH1 mutations among cancer patients, enhanced awareness around targeted treatments, and a surge in oncology-focused research and development.

The tibsovo market size is expected to see strong growth in the next few years. It will grow to $1.55 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. This anticipated expansion is due to the rising preference for targeted cancer medications, broader use of IDH1 inhibitors, heightened investment in biopharmaceutical R&D, and favorable regulatory pathways. Key trends anticipated during the forecast period include growth in precision oncology innovations, strategic alliances and partnerships, progress in small-molecule drug innovations, regulatory green lights, and evolution in therapeutic protocols.

The increasing prevalence of acute myeloid leukemia is expected to propel the growth of the Tibsovo market going forward. Acute myeloid leukemia (AML) is an aggressively progressing cancer of the blood and bone marrow that directly impacts blood cell production, immune function, and overall physical health. This rise in prevalence is largely attributed to the global increase in the aging population, as AML primarily affects older adults. With longer life expectancy, more individuals are reaching the age group most vulnerable to developing this type of leukemia. Tibsovo addresses AML by targeting IDH1-mutated cancer cells to inhibit abnormal cell growth, reduce disease progression, improve treatment response, and enhance survival outcomes by restoring normal blood cell production. For example, in February 2023, the Leukemia Foundation, an Australia-based non-profit organization, reported that between 2022 and 2035, over 7,000 children, 6,000 young adults, and 108,000 adults (aged 25-65) are expected to be diagnosed with blood cancers, primarily including ALL, AML, and non-Hodgkin lymphoma. As a result, the rising prevalence of acute myeloid leukemia is fueling the growth of the Tibsovo market.

Major companies operating in the Tibsovo market are focusing on obtaining regulatory approvals to broaden the drug's reach and sustain leadership in IDH1-mutated cancers. Regulatory approvals refer to the official permissions granted by health authorities that enable a drug to be legally marketed and used for designated medical conditions after its safety and effectiveness are confirmed. For instance, in October 2023, Servier Laboratoires, a France-based pharmaceutical company, received approval from the European Commission for Tibsovo (ivosidenib tablets), making it the first and only IDH1-targeted therapy authorized in Europe for two difficult-to-treat cancer types. The drug is approved for use in combination with azacitidine for newly diagnosed AML patients with an IDH1 R132 mutation who are ineligible for standard induction chemotherapy, and as a monotherapy for adults with locally advanced or metastatic cholangiocarcinoma harboring the same mutation after at least one prior systemic treatment. This approval, which benefits from orphan drug designation, fulfills critical unmet medical needs and offers new hope for improved outcomes and quality of life for these patients.

In December 2023, Servier Group, a France-based pharmaceutical company offering Tibsovo (ivosidenib tablets) as a targeted therapy for patients with IDH1-mutated cancers, acquired exclusive rights to develop, manufacture, and commercialize Tibsovo from CStone Pharmaceuticals for $44 million. This strategic acquisition aims to expand Servier Group's presence in the rapidly growing China and Singapore markets by securing exclusive rights to Tibsovo. It also strengthens the company's oncology portfolio with a targeted therapy for IDH1-mutated cancers and accelerates patient access to this innovative treatment in these key regions. CStone Pharmaceuticals is a China-based biopharmaceutical company that specializes in oncology treatments.

Major players in the tibsovo market are Servier Laboratoires, and Agios Pharmaceuticals.

North America was the largest region in the tibsovo market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tibsovo report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tibsovo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tibsovo market consists of sales of products including oral tablets, extended-release tablets, soft gel capsules, intravenous injection, and subcutaneous injection. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tibsovo Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tibsovo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tibsovo ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tibsovo market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Tablets; Capsules; Combination Therapy; Injectable Forms
• 2) By Drug Administration: Oral Administration; Intravenous Administration
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 4) By Application: Cancer Treatment; Acute Myeloid Leukemia; Chemotherapy; Targeted Therapy
• 5) By End User: Hospitals; Specialty Clinics; Research Institutions; Homecare Settings
• Subsegments:

1) By Tablets; Oral Tablets; Extended-Release Tablets

2) By Capsules; Soft Gel Capsules; Hard Gel Capsules

3) By Combination Therapy; Tibsovo + Chemotherapy Agents; Tibsovo + Targeted Therapy Agents

4) By Injectable Forms; Intravenous Injection; Subcutaneous Injection

• Companies Mentioned: Servier Laboratoires; Agios Pharmaceuticals;
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tibsovo Market Characteristics

3. Tibsovo Market Trends And Strategies

4. Tibsovo Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tibsovo Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tibsovo PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tibsovo Market Growth Rate Analysis
• 5.4. Global Tibsovo Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tibsovo Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tibsovo Total Addressable Market (TAM)

6. Tibsovo Market Segmentation

• 6.1. Global Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Combination Therapy
• Injectable Forms
• 6.2. Global Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Administration
• Intravenous Administration
• 6.3. Global Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Tibsovo Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Treatment
• Acute Myeloid Leukemia
• Chemotherapy
• Targeted Therapy
• 6.5. Global Tibsovo Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Research Institutions
• Homecare Settings
• 6.6. Global Tibsovo Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Tablets
• Extended-Release Tablets
• 6.7. Global Tibsovo Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Soft Gel Capsules
• Hard Gel Capsules
• 6.8. Global Tibsovo Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tibsovo + Chemotherapy Agents
• Tibsovo + Targeted Therapy Agents
• 6.9. Global Tibsovo Market, Sub-Segmentation Of Injectable Forms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous Injection
• Subcutaneous Injection

7. Tibsovo Market Regional And Country Analysis

• 7.1. Global Tibsovo Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tibsovo Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tibsovo Market

• 8.1. Asia-Pacific Tibsovo Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tibsovo Market

• 9.1. China Tibsovo Market Overview
• 9.2. China Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tibsovo Market

• 10.1. India Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tibsovo Market

• 11.1. Japan Tibsovo Market Overview
• 11.2. Japan Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tibsovo Market

• 12.1. Australia Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tibsovo Market

• 13.1. Indonesia Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tibsovo Market

• 14.1. South Korea Tibsovo Market Overview
• 14.2. South Korea Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tibsovo Market

• 15.1. Western Europe Tibsovo Market Overview
• 15.2. Western Europe Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tibsovo Market

• 16.1. UK Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tibsovo Market

• 17.1. Germany Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tibsovo Market

• 18.1. France Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tibsovo Market

• 19.1. Italy Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tibsovo Market

• 20.1. Spain Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tibsovo Market

• 21.1. Eastern Europe Tibsovo Market Overview
• 21.2. Eastern Europe Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tibsovo Market

• 22.1. Russia Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tibsovo Market

• 23.1. North America Tibsovo Market Overview
• 23.2. North America Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tibsovo Market

• 24.1. USA Tibsovo Market Overview
• 24.2. USA Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tibsovo Market

• 25.1. Canada Tibsovo Market Overview
• 25.2. Canada Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tibsovo Market

• 26.1. South America Tibsovo Market Overview
• 26.2. South America Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tibsovo Market

• 27.1. Brazil Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tibsovo Market

• 28.1. Middle East Tibsovo Market Overview
• 28.2. Middle East Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tibsovo Market

• 29.1. Africa Tibsovo Market Overview
• 29.2. Africa Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tibsovo Market Competitive Landscape And Company Profiles

• 30.1. Tibsovo Market Competitive Landscape
• 30.2. Tibsovo Market Company Profiles
  • 30.2.1. Servier Laboratoires Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Agios Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

31. Global Tibsovo Market Competitive Benchmarking And Dashboard

32. Key Mergers And Acquisitions In The Tibsovo Market

33. Recent Developments In The Tibsovo Market

34. Tibsovo Market High Potential Countries, Segments and Strategies

• 34.1 Tibsovo Market In 2029 - Countries Offering Most New Opportunities
• 34.2 Tibsovo Market In 2029 - Segments Offering Most New Opportunities
• 34.3 Tibsovo Market In 2029 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer